The best indicator for Ally
We backtested 382 indicators across daily, weekly and hourly charts on real Ally history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
DEMA 10/30 Cross
On the weekly chart, this is the strongest risk-adjusted edge we found for Ally over ~12.5 years — beating buy-and-hold by 6.4% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | DEMA 10/30 Cross ✓ | Weekly | 13.6% | 0.7 | -35.3% | 57.1% | 14 | 6.4% |
| 2 | Price Momentum Oscillator ✓ | Weekly | 14.7% | 0.75 | -35.3% | 58.3% | 12 | 7.5% |
| 3 | TRIX ✓ | Weekly | 9.8% | 0.56 | -35.3% | 60.0% | 15 | 2.6% |
| 4 | Know Sure Thing ✓ | Weekly | 9.9% | 0.56 | -35.3% | 43.8% | 16 | 2.7% |
| 5 | Bullish Engulfing ✓ | Weekly | 6.6% | 0.55 | -28.1% | 57.1% | 21 | -0.6% |
| 6 | SMC: Change of Character ✓ | Daily | 10.5% | 0.52 | -68.4% | 54.8% | 31 | 3.4% |
| 7 | Positive Volume Index ✓ | Daily | 8.3% | 0.51 | -39.6% | 27.8% | 36 | 1.2% |
| 8 | Volatility Regime (VIX-style) ✓ | Daily | 7.9% | 0.51 | -30.3% | 41.6% | 101 | 0.7% |
| 9 | Hull MA 100 Trend ✓ | Weekly | 7.9% | 0.5 | -29.0% | 44.4% | 18 | 0.7% |
| 10 | LSMA 100 Trend ✓ | Weekly | 7.7% | 0.5 | -31.1% | 52.6% | 19 | 0.5% |
| 11 | Hull MA 20/80 Cross ✓ | Weekly | 14.4% | 0.75 | -35.3% | 80.0% | 10 | 7.2% |
| 12 | SMC: Order Block ✓ | Weekly | 9.6% | 0.53 | -40.9% | 57.1% | 14 | 2.4% |
| 13 | Ulcer Index ✓ | Weekly | 7.2% | 0.49 | -33.0% | 56.2% | 16 | -0.0% |
| 14 | Volume Flow Indicator ✓ | Daily | 8.0% | 0.47 | -29.7% | 44.8% | 29 | 0.8% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Ally, DEMA 10/30 Cross on the weekly timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.